The first pharmaceutical for eosinophilic esophagitis approved in the U.S.

The U.S. Drug Administration has approved the drug Dupixent (dupilumab) to treat inflammation of the oesophagus of the type eosinophil esophagitis.

Brexit looking back and looking forward

More than 3 years have passed after the vote and there is still uncertainty around the outcome although the UK December 12 election set a clearer course towards...

We will now publish more news in English – and offer yet another newsletter

Starting next week, Life Science Sweden will begin offering a newsletter entirely in English.

Product Specialist at Gradientech AB, Uppsala

Smart att annonsera på Google

Idag när internet är en stor del av de flestas vardag, så gäller det att som företag synas där på ett bra sätt. Dels är det bra om man har en egen hemsida, som ...

Anna Törner: You won’t find this many Concorde projects anywhere else

"Suddenly Concorde projects seem reasonable in life science because it´s about life and death", writes Anna Törner in a column.

MVA:s CEO: “Our investments should improve people´s everyday lives”

Involuntary infertility and diabetes are two of the areas on the agenda of the Medicon Valley Alliance.

Pharma-on-Demand

Make or buy? That is the question that the pharma world has been asking more and more in the last couple of decades. Pernille Hemmingsen is moderator at Pharma ...

The Oresund region aims at becoming Europe’s microbiome Mecca

The Medicon Valley Alliance’s ambition: Skåne and the Copenhagen region will become world leaders in microbiome research.

Sweden is organising a large life science conference as part of the EU presidency

On 26-27 June, Sweden will host a European meeting on life science.

Before you choose a CRO

– We are a small company and it is very important for us to maintain our core competence within development of novel nanomaterials, Tove Sivik Sonne, Head of De...

How to become globally competitive

Here Gunilla Osswald from BioArctic share her experience of scaling up and be competative on the global arena.

Marie Gårdmark: Big data evidence generation drives change in the EU regulatory system

Rapid developments in technology have led to the possibility for the generation and analysis of vast volumes of data. Will the availability of big data lead to ...

Högteknologiska bolag allt mer intresserade av hälsa

Under många år har techföretag intresserat sig för hälso- och sjukvården och det intresset ser ut att öka. ”Det är inget plötsligt trendbrott, det handlar mer o...

Webinar: What is Regulatory Affairs?

This webinar is intended for those who work within the life science sector and would like to gain a general understanding of regulatory affairs for human medicinal products.

Björn Arvidsson: Let's build on the positive momentum

Progress needs narratives and heroes, and more than ever, going into the new year feels like an opportunity for a fresh start.

Norway finds its path in life science

The life science sector in Norway is on the rise.

Samuel Lagercrantz: Collaboration and joint efforts are the key to success

Although many questions about Covid-19 remain unanswered, the development of drugs and vaccines has been incredibly rapid, writes Samuel Lagercrantz, Life Scien...

Keanu Reeves ger namn åt molekyler som är effektiva mot svampsjukdomar

Tyska forskare presenterar svampdödande molekyler, keanumyciner, som är verksamma mot bland annat Candida albicans – en svamp som kan angripa människa.

It´s time to establish relations

Communication with the patient is the key to future healthcare, writes Hanna Brodda, editor in chief of Life Science Sweden.

The most important Swedish medical innovations: Our ranking

Life Science Sweden turns 20 years old – and celebrates by producing a top list of the 20 most important contemporary Swedish innovations in the field of medicine.

New diagnostic test soon ready for the market

Index Pharmaceuticals rekryterar inför fas III-studie

Anställer Anders Bröijersén och Johan Levin till den kliniska utvecklingsorganisationen.

Här är läkemedelsföretagen som är bäst förberedda på AI

Hur väl förberedda är läkemedelsföretag inom området artificiell intelligens? Det framgår av en ny utvärdering.